Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tango Therapeutics, Inc. - Common Stock (NQ:TNGX)

4.790 +0.100 (+2.13%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,038,757
Open 4.660
Bid (Size) 4.570 (2)
Ask (Size) 4.990 (2)
Prev. Close 4.690
Today's Range 4.400 - 4.880
52wk Range 1.030 - 12.02
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Sarepta Therapeutics, KULR Technology Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Quanex Building Products, Manchester United, Byrna Technologies And Other Big Stocks Moving Higher On Friday
Via Benzinga

Performance

YTD
+53.0%
+53.0%
1 Month
+219.3%
+219.3%
3 Month
+145.6%
+145.6%
6 Month
+62.4%
+62.4%
1 Year
-48.9%
-48.9%

More News

Read More
What's going on in today's session
Via Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Earnings Scheduled For May 12, 2025
Via Benzinga
Insights into Tango Therapeutics's Upcoming Earnings
Via Benzinga
Unveiling 5 Analyst Insights On Tango Therapeutics
Via Benzinga
Which stocks are experiencing notable movement on Monday?
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Tango Therapeutics, Inc.
Via Business Wire
Tango Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference
From Tango Therapeutics, Inc.
Via Business Wire
The Analyst Landscape: 5 Takes On Tango Therapeutics
Via Benzinga
Analyst Scoreboard: 4 Ratings For Tango Therapeutics
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Tango Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights
From Tango Therapeutics, Inc.
Via Business Wire
Tango Therapeutics Reports Positive TNG462 Clinical Data and Provides Update on PRMT5 Development Program
From Tango Therapeutics, Inc.
Via Business Wire
Analyst Expectations For Tango Therapeutics's Future
Via Benzinga
Expert Outlook: Tango Therapeutics Through The Eyes Of 6 Analysts
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Tango Therapeutics to Participate in Upcoming Investor Conferences
From Tango Therapeutics, Inc.
Via Business Wire
Tango Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights
From Tango Therapeutics, Inc.
Via Business Wire
Tango Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
From Tango Therapeutics, Inc.
Via Business Wire
Forecasting The Future: 4 Analyst Projections For Tango Therapeutics
Via Benzinga
Tango Therapeutics Shuts Early-Stage Cancer Study Due To Liver Toxicity
Via Benzinga

Frequently Asked Questions

Is Tango Therapeutics, Inc. - Common Stock publicly traded?
Yes, Tango Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Tango Therapeutics, Inc. - Common Stock trade on?
Tango Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Tango Therapeutics, Inc. - Common Stock?
The ticker symbol for Tango Therapeutics, Inc. - Common Stock is TNGX on the Nasdaq Stock Market
What is the current price of Tango Therapeutics, Inc. - Common Stock?
The current price of Tango Therapeutics, Inc. - Common Stock is 4.790
When was Tango Therapeutics, Inc. - Common Stock last traded?
The last trade of Tango Therapeutics, Inc. - Common Stock was at 06/16/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.